| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/PDS.2083 |
| P698 | PubMed publication ID | 21523847 |
| P50 | author | Giovanni de Girolamo | Q30090007 |
| Angelo Picardi | Q40429397 | ||
| P2093 | author name string | Paola Rucci | |
| Antonio Preti | |||
| Giovanni Santone | |||
| Cesario Bellantuono | |||
| P2860 | cites work | The current state of mental health care in Italy: problems, perspectives, and lessons to learn | Q28281604 |
| The management of bipolar mania: a national survey of baseline data from the EMBLEM study in Italy | Q31119259 | ||
| Results of a longitudinal analysis of national data to examine relationships between organizational and market characteristics and changes in antipsychotic prescribing in US nursing homes from 1996 through 2006. | Q33483929 | ||
| Characteristics and activities of acute psychiatric in-patient facilities: national survey in Italy | Q34005435 | ||
| Influence of antipsychotics on mortality in schizophrenia: systematic review. | Q34018034 | ||
| National trends in psychotropic medication polypharmacy in office-based psychiatry | Q34090959 | ||
| Antipsychotic dosing patterns for schizophrenia in three treatment settings | Q34120453 | ||
| Influence of facility characteristics on use of antipsychotic medications in nursing homes | Q34143919 | ||
| Polypharmacy and excessive dosing: psychiatrists' perceptions of antipsychotic drug prescription. | Q34447495 | ||
| Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinations | Q34941330 | ||
| Antipsychotic medication coprescribing in a large state hospital system | Q35077883 | ||
| The use of prescribing indicators to measure the quality of care in psychiatric inpatients | Q35561996 | ||
| Combination of "atypical" antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder | Q35612449 | ||
| Antipsychotic polypharmacy in patients with schizophrenia: a multicentre comparative study in East Asia | Q35826319 | ||
| Antipsychotic polypharmacy | Q35849635 | ||
| Simultaneous prescribing of atypical antipsychotics, conventional antipsychotics and anticholinergics-a European study | Q35884276 | ||
| Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003. | Q36767032 | ||
| Antipsychotic prescriptions in a university hospital outpatient population in Turkey: a retrospective database analysis, 2005-2006. | Q37075091 | ||
| Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials | Q37137001 | ||
| Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study | Q37220015 | ||
| Does antipsychotic polypharmacy increase the risk for metabolic syndrome? | Q37281587 | ||
| Antipsychotic polypharmacy in patients with schizophrenia in a brief hospitalization unit | Q37339568 | ||
| Polypharmacy with second-generation antipsychotics: a review of evidence | Q37341522 | ||
| Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies | Q37670925 | ||
| The process of care in residential facilities--a national survey in Italy | Q40398631 | ||
| Pattern of therapeutic intervention and role of psychiatric settings: a survey in two regions of Italy | Q41456397 | ||
| Antipsychotic prescribing practices in Connecticut's public mental health system: rates of changing medications and prescribing styles | Q44016015 | ||
| Mortality in schizophrenia. Antipsychotic polypharmacy and absence of adjunctive anticholinergics over the course of a 10-year prospective study | Q44022663 | ||
| Augmentation of clozapine with a second antipsychotic--a meta-analysis of randomized, placebo-controlled studies. | Q46107829 | ||
| Increased risk of extrapyramidal side-effect treatment associated with atypical antipsychotic polytherapy | Q46901295 | ||
| The prescription of psychotropic drugs in psychiatric residential facilities: a national survey in Italy | Q46934245 | ||
| Patterns of admission to acute psychiatric in-patient facilities: a national survey in Italy. | Q50786467 | ||
| Structural and organizational determinants of quality of care in patients with schizophrenia in Italy. | Q51874416 | ||
| Antipsychotic use at adult ambulatory care visits by patients with mental health disorders in the United States, 1996-2003: national estimates and associated factors. | Q51901734 | ||
| Validation of polypharmacy process measures in inpatient schizophrenia care. | Q51929063 | ||
| Guideline adherence in medication management of psychotic disorders: an observational multisite hospital study. | Q51929110 | ||
| Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits. | Q51942046 | ||
| Combination antipsychotic therapy in clinical practice. | Q51951314 | ||
| Persistence with polypharmacy and excessive dosing in patients with schizophrenia treated in four European countries | Q57470966 | ||
| Variation in Nursing Home Antipsychotic Prescribing Rates | Q58070500 | ||
| Introduzione | Q58324398 | ||
| P433 | issue | 5 | |
| P921 | main subject | Italy | Q38 |
| patient | Q181600 | ||
| P304 | page(s) | 441-449 | |
| P577 | publication date | 2010-12-23 | |
| P1433 | published in | Pharmacoepidemiology and Drug Safety | Q15759496 |
| P1476 | title | Patient characteristics and process factors associated with antipsychotic polypharmacy in a nationwide sample of psychiatric inpatients in Italy. | |
| P478 | volume | 20 |
| Q34686544 | Antipsychotic patterns of use in patients with schizophrenia: polypharmacy versus monotherapy |
| Q50709810 | Antipsychotic polypharmacy and high-dose prescription in schizophrenia: a 5-year comparison. |
| Q37029622 | Antipsychotic polypharmacy: a comprehensive evaluation of relevant correlates of a long-standing clinical practice |
| Q33560808 | Antipsychotic prescribing for vulnerable populations: a clinical audit at an acute Australian mental health unit at two-time points |
| Q38020263 | Critical review of antipsychotic polypharmacy in the treatment of schizophrenia |
| Q50036057 | Economic burden of schizophrenia in Italy: a probabilistic cost of illness analysis |
| Q37579469 | Efficacy and clinical determinants of antipsychotic polypharmacy in psychotic patients experiencing an acute relapse and admitted to hospital stay: results from a cross-sectional and a subsequent longitudinal pilot study |
| Q48453000 | Frontal lobe function and social adjustment in patients with schizophrenia: near-infrared spectroscopy |
| Q38766834 | Gender differences and psychotropic polypharmacy in psychiatric patients in Brazil: a cross-sectional analysis of the PESSOAS Project |
| Q42860052 | Prescription patterns for patients with schizophrenia in Korea: a focus on antipsychotic polypharmacy. |
| Q39885395 | Quality of care indicators for schizophrenia: determinants of observed variations among Italian Departments of Mental Health. Results from the ETAS DSM study |
| Q40269113 | Social and clinical descriptors of antipsychotic prescription |
Search more.